Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05335889 · ClinicalTrials.gov registry record
Wearable Sensors and Artificial Intelligence for Carbohydrate Counting
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 12
- Enrollment target
NCT05335889 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 12 participants.
The verdict
NCT05335889 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This is a one-group pilot study where Chinese immigrants who are English speaking with T2D from NYU Langone Health and NYU Brooklyn Family Health Center (Sunset Park) will be recruited.
Interventions
- DEVICE Continuous Glucose Monitoring (CGM)
- DEVICE eButton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-07-18 |
| Est. Completion | 2023-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05335889
The ClinicalTrials.gov registry entry for NCT05335889 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitoring (CGM) is the first listed.
NCT05335889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05335889 about?
NCT05335889 is a clinical study titled "Wearable Sensors and Artificial Intelligence for Carbohydrate Counting". This is a one-group pilot study where Chinese immigrants who are English speaking with T2D from NYU Langone Health and NYU Brooklyn Family Health Center (Sunset Park) will be recruited.
What is the current status of trial NCT05335889?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2022-07-18. Estimated completion is 2023-09-22.
What interventions are being tested in trial NCT05335889?
The interventions under investigation include: Continuous Glucose Monitoring (CGM) (DEVICE), eButton (DEVICE).
Who is sponsoring clinical trial NCT05335889?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.